OptiRTP CEO Jon Doherty attended AUT’s Future of Health: Where Aotearoa Leads Next conference, joining leaders from across New Zealand’s health system to discuss the next phase of healthcare innovation.
Archive for the
‘Company News’ Category
OptiRTP presented its U.S. market entry strategy and clinical validation roadmap to more than 40 current and prospective investors at a private briefing held at Buddle Findlay’s Auckland office on 6 November 2025.
